April 12, 2024
TOPLINE: Endoscopic sleeve gastroplasty (ESG) is more cost-effective, and achieves and sustains greater weight loss, than semaglutide over a 5-year period in patients with class II […]
April 12, 2024
TOPLINE: A recent survey highlighted ethical concerns US oncologists have about using artificial intelligence (AI) to help make cancer treatment decisions and revealed some contradictory views […]
April 12, 2024
TOPLINE: For individuals aged 45-49 years at average risk for colorectal cancer (CRC), the adenoma detection rate (ADR) in screening colonoscopies is 28%, which is comparable […]
April 12, 2024
TOPLINE: Adolescents with type 1 diabetes (T1D) experience a similar incidence of nighttime hypoglycemia after exercise as after sedentary days, reports a study exploring factors that […]
April 12, 2024
TOPLINE: No significant association was found between the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and thyroid cancer over nearly 4 years. METHODOLOGY: A […]
April 12, 2024
TOPLINE: According to this meta-analysis, psoriatic arthritis (PsA) affects 112 out of every 100,000 adults globally, with higher rates observed in Europe and North America than […]
April 12, 2024
TOPLINE: Higher levels of body fat and visceral adipose tissue are associated with increased functional disability and reduced spinal mobility in patients with axial spondyloarthritis (axSpA) […]
April 12, 2024
TOPLINE: Patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) have a high risk for serious and fatal infections, with age, inflammation, and corticosteroid therapy further increasing […]
April 12, 2024
TOPLINE: Subcutaneous tocilizumab provides durable disease control rates in patients with polyarticular and systemic juvenile idiopathic arthritis (pJIA and sJIA, respectively). METHODOLOGY: This long-term extension (LTE) […]